- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Goodrx Holdings Inc (GDRX)
Goodrx Holdings Inc stock price live, this page displays NASDAQ GDRX stock exchange data. View the GDRX premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Goodrx Holdings Inc real time stock price chart below.
What Is the Goodrx Holdings Inc Stock Price Today?
The Goodrx Holdings Inc stock price today is 4.60.
What Is the Stock Symbol for Goodrx Holdings Inc?
The stock symbol for Goodrx Holdings Inc is "GDRX."
What Stock Exchange Does Goodrx Holdings Inc Trade On?
Goodrx Holdings Inc is listed and trades on the NASDAQ stock exchange.
Is Goodrx Holdings Inc a Good Stock to Buy?
Determining whether Goodrx Holdings Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the GDRX quote. (ISIN: US38246G1085)
What Is the Goodrx Holdings Inc Stock Price Today?
The Goodrx Holdings Inc stock price today is 4.60.
What Is the Stock Symbol for Goodrx Holdings Inc?
The stock symbol for Goodrx Holdings Inc is "GDRX."
What Stock Exchange Does Goodrx Holdings Inc Trade On?
Goodrx Holdings Inc is listed and trades on the NASDAQ stock exchange.
Is Goodrx Holdings Inc a Good Stock to Buy?
Determining whether Goodrx Holdings Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the GDRX quote. (ISIN: US38246G1085)
4.60
+0.12(+2.57%)
Real-time Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
4.47
4.66
52 wk Range
3.68
9.26
GDRX Scorecard
Full Analysis
Management has been aggressively buying back shares
GDRX is not included in our AI-picked strategies. See which stocks are.
Review Strategies
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
4.474.66
52 wk Range
3.689.26
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
GDRX Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Price Target
6.32
Upside
+37.32%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
High shareholder yield
Goodrx Holdings Inc Company Profile
GoodRx Holdings, Inc., together with its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices. It also offers other healthcare products and services, including subscriptions and pharma manufacturer solutions, as well as telehealth services through the GoodRx Care platform. In addition, the company provides healthcare products and solution for dogs, cats, and other pets. It serves pharmacy benefit managers who manage formularies and prescription transactions, including establishing pricing between consumers and pharmacies. The company was founded in 2011 and is headquartered in Santa Monica, California.
Goodrx Holdings Inc SWOT Analysis
Digital Health Pionee | GoodRx leads in prescription savings, leveraging its platform to make healthcare more affordable amid evolving pharmacy landscape challenges |
Financial Resilience | Explore GoodRx's robust financials, including high gross profit margins and strong free cash flow yield, despite industry headwinds |
Growth Strategies | Delve into GoodRx's focus on Pharma Manufacturer Solutions and Integrated Savings Program as key drivers for future expansion |
Market Dynamics | Learn how GoodRx navigates competitive pressures and pharmacy closures while analysts set price targets ranging from $4.25 to $10 |
Goodrx Holdings Inc Earnings Call Summary for Q1/2025
- GoodRx Q1 2025 EPS met expectations at $0.09; revenue slightly beat at $202.97M, up 3% YoY; stock surged 8.44% premarket
- Adjusted EBITDA grew 11% YoY to $69.8M; company repurchased $100M in stock, enhancing shareholder value
- Full-year 2025 revenue guidance: $810M-$840M (2-6% growth); adjusted EBITDA projected to grow 5-10% to $273M-$287M
- CEO emphasized durable business model; CFO noted strategic stock repurchases as 'highly accretive' given current valuation
- Minimal impact expected from Rite Aid bankruptcy; company exploring opportunities with GLP-1 medication manufacturers
Last Updated: 2025/05/08, 15:20
Read Full TranscriptCompare GDRX to Peers and Sector
Metrics to compare | GDRX | Sector Sector - Average of metrics from a broad group of related Technology sector companies | Relationship RelationshipGDRXPeersSector | |
|---|---|---|---|---|
P/E Ratio | 62.0x | −1.4x | −0.5x | |
PEG Ratio | 0.11 | 0.00 | 0.00 | |
Price/Book | 2.7x | 1.1x | 2.6x | |
Price / LTM Sales | 2.2x | 1.4x | 3.0x | |
Upside (Analyst Target) | 30.2% | 27.1% | 51.9% | |
Fair Value Upside | Unlock | 27.2% | 8.9% | Unlock |
Analyst Ratings
8 Buy
7 Hold
1 Sell
Ratings:
16 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 6.32
(+37.32% Upside)
Earnings
Latest Release
May 07, 2025
EPS / Forecast
0.09 / 0.09
Revenue / Forecast
202.97M / 202.59M
FAQ
What Is the Goodrx (GDRX) Stock Price Today?
The Goodrx stock price today is 4.60
What Stock Exchange Does Goodrx Trade On?
Goodrx is listed and trades on the Nasdaq Stock Exchange stock exchange.
What Is the Stock Symbol for Goodrx?
The stock symbol for Goodrx is "GDRX."
What Is the Goodrx Market Cap?
As of today, Goodrx market cap is 1.76B.
What Is Goodrx's Earnings Per Share (TTM)?
The Goodrx EPS (TTM) is 0.07.
When Is the Next Goodrx Earnings Date?
Goodrx will release its next earnings report on 06 Aug 2025.
From a Technical Analysis Perspective, Is GDRX a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Goodrx Stock Split?
Goodrx has split 0 times.
How Many Employees Does Goodrx Have?
Goodrx has 738 employees.
What is the current trading status of Goodrx (GDRX)?
As of 20 Jun 2025, Goodrx (GDRX) is trading at a price of 4.60, with a previous close of 4.48. The stock has fluctuated within a day range of 4.47 to 4.66, while its 52-week range spans from 3.68 to 9.26.
What Is Goodrx (GDRX) Price Target According to Analysts?
The average 12-month price target for Goodrx is USD6.31667, with a high estimate of USD9 and a low estimate of USD4. 8 analysts recommend buying the stock, while 1 suggest selling, leading to an overall rating of Buy. The stock has an +37.32% Upside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.